Avicanna Financials
| AVCNF Stock | USD 0.25 0.04 19.05% |
With this module, you can analyze Avicanna financials for your investing period. You should be able to track the changes in Avicanna individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Avicanna |
Understanding current and past Avicanna Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Avicanna's financial statements are interrelated, with each one affecting the others. For example, an increase in Avicanna's assets may result in an increase in income on the income statement.
The data published in Avicanna's official financial statements typically reflect Avicanna's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Avicanna's quantitative information. For example, before you start analyzing numbers published by Avicanna accountants, it's essential to understand Avicanna's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Avicanna Stock Summary
Avicanna competes with Genomma Lab. Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada. Avicanna operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 124 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQX Exchange |
| Business Address | 480 University Avenue, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.avicanna.com |
| Phone | 647 243 5283 |
| Currency | USD - US Dollar |
Avicanna Key Financial Ratios
There are many critical financial ratios that Avicanna's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Avicanna reports annually and quarterly.| Return On Equity | -1.69 | |||
| Return On Asset | -0.22 | |||
| Number Of Employees | 124 | |||
| Beta | 1.94 | |||
| Z Score | 33.0 |
Avicanna Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avicanna's current stock value. Our valuation model uses many indicators to compare Avicanna value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avicanna competition to find correlations between indicators driving Avicanna's intrinsic value. More Info.Avicanna is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avicanna's earnings, one of the primary drivers of an investment's value.Avicanna Systematic Risk
Avicanna's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Avicanna volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Avicanna correlated with the market. If Beta is less than 0 Avicanna generally moves in the opposite direction as compared to the market. If Avicanna Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Avicanna is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Avicanna is generally in the same direction as the market. If Beta > 1 Avicanna moves generally in the same direction as, but more than the movement of the benchmark.
Avicanna December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Avicanna help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Avicanna. We use our internally-developed statistical techniques to arrive at the intrinsic value of Avicanna based on widely used predictive technical indicators. In general, we focus on analyzing Avicanna OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Avicanna's daily price indicators and compare them against related drivers.
| Downside Deviation | 11.77 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 44.0 | |||
| Value At Risk | (15.00) | |||
| Potential Upside | 17.86 |
Complementary Tools for Avicanna OTC Stock analysis
When running Avicanna's price analysis, check to measure Avicanna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avicanna is operating at the current time. Most of Avicanna's value examination focuses on studying past and present price action to predict the probability of Avicanna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avicanna's price. Additionally, you may evaluate how the addition of Avicanna to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |